Filter posts

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

BIO 2017 Patient and Health Advocacy Summit Explores Best Practices in State Advocacy

The first day of BIO’s Patient Health & Advocacy Summit concluded with a breakout session …

Three Encouraging Steps on Prescription Drug Costs

It’s a refrain you hear often in the news: Drug costs are soaring and nothing …

The Dangers of Drug Importation

The United States is the leader in biopharmaceutical innovation and in guaranteeing that our prescription …

Sticking to the Facts on Drug Pricing

Former President John Adams is known to have once said, “Facts are stubborn things,” and …

Former UK Prime Minister David Cameron Zeroes in on Alzheimer’s Research at BIO 2017

Five years ago, during the height of his leadership, then-Prime Minister David Cameron of the …

"How to Make Medicine More Expensive."

That’s the appropriate title of a Wall Street Journal editorial released earlier this week, which …

New Resource Center – One-Stop for All Things Lupus

A keen understanding of the education and support needs of all those impacted by lupus …

New Report Shows Drug Spending Growth Slows Dramatically

Contrary to continued misleading claims about the increasing costs of prescription medicines, a new report …

ICYMI: Jim Greenwood’s Letter in NYT on Drug Importation

Yesterday, the New York Times published a letter to the editor from BIO’s President and …